Teva Pharmaceutical Industries Limited
36.85USD
+0.0900 (+0.24%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.7▲ | $0.42 | 6 | 3 |
| Next quarter | $0.74▲ | $0.71 | 6 | 3 |
| Current year | $2.14▼ | $2.37 | 2 | 5 |
| Next year | $3.07▼ | $3.1 | 3 | 6 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.11 | $0.02 | -0.09 (-81.5%) |
| 2026-03-31 | $0.46 | $0.53 | +0.07 (+16.2%) |
| 2025-12-31 | $0.64 | $0.96 | +0.32 (+50.2%) |
| 2025-09-30 | $0.67 | $0.78 | +0.11 (+15.7%) |
275 ratings from 45 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Buy | $42 $48 | Sep 4, 2026 |
| Barclays | Maintained | Overweight | $40 $42 | Aug 12, 2026 |
| Piper Sandler | Maintained | Overweight | $42 $44 | Jul 28, 2026 |
| Barclays | Maintained | Overweight | $38 $40 | May 6, 2026 |
| JP Morgan | Maintained | Overweight | $35 $40 | Apr 30, 2026 |
| UBS | Maintained | Buy | $36 $42 | Apr 30, 2026 |
| Piper Sandler | Reiterated | Overweight | $41 $42 | Apr 30, 2026 |
| Truist Securities | Maintained | Buy | $42 $45 | Apr 30, 2026 |
| B of A Securities | Maintained | Buy | $38 $42 | Apr 9, 2026 |
| Piper Sandler | Reiterated | Overweight | $40 $41 | Mar 4, 2026 |
| Truist Securities | Maintained | Buy | $38 $42 | Feb 18, 2026 |
| Goldman Sachs | Maintained | Buy | $36 $45 | Feb 9, 2026 |
| Barclays | Maintained | Overweight | $35 $38 | Jan 30, 2026 |
| Scotiabank | Maintained | Sector Outperform | $35 $40 | Jan 29, 2026 |
| Truist Securities | Maintained | Buy | $36 $38 | Jan 29, 2026 |
| Jefferies | Maintained | Buy | $29 $40 | Jan 6, 2026 |
| Piper Sandler | Maintained | Overweight | $30 $40 | Dec 22, 2025 |
| Goldman Sachs | Maintained | Buy | $31 $35 | Dec 19, 2025 |
| JP Morgan | Maintained | Overweight | $28 $35 | Dec 16, 2025 |
| B of A Securities | Maintained | Buy | $29 $32 | Dec 9, 2025 |
| Barclays | Initiated | Overweight | $35 | Dec 9, 2025 |
| Goldman Sachs | Maintained | Buy | $28 $31 | Dec 8, 2025 |
| Scotiabank | Initiated | Sector Outperform | $35 | Dec 5, 2025 |
| JP Morgan | Maintained | Overweight | $26 $28 | Nov 6, 2025 |
| JP Morgan | Maintained | Overweight | $23 $26 | Oct 3, 2025 |
73 filings from 20 insiders · 10 buy / 11 sell over 6m
Officers and directors of TEVA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SATCHI-FAINARO RONITDirector | Sell | 415 | $37.25 | $15k | Aug 21, 2026 |
| LIPPMAN EVANOfficer | Sell | 18.6k | $36.57 | $680k | Aug 17, 2026 |
| ZAKS TAL ZVIDirector | Sell | 17 | $34.87 | $593 | Aug 5, 2026 |
| SHIELDS MATTHEWOfficer | Sell | 10.0k | $32.19 | $322k | Jun 18, 2026 |
| ZAKS TAL ZVIDirector | Other | 14.5k | — | — | Jun 5, 2026 |
| SATCHI-FAINARO RONITDirector | Other | 14.5k | — | — | Jun 5, 2026 |
| LICHTENSTEIN CHENDirector | Other | 14.5k | — | — | Jun 5, 2026 |
| SABAG MARKOfficer | Sell | 144.2k | $34.99 | $5.05M | May 1, 2026 |
| FOX CHRISTINEOfficer | Sell | 21.3k | $35.31 | $751k | Apr 30, 2026 |
| HUGHES ERIC AOfficer | Sell | 9.5k | $31.67 | $302k | Mar 5, 2026 |
| FOX CHRISTINEOfficer | Sell | 7.9k | $31.67 | $251k | Mar 5, 2026 |
| SHIELDS MATTHEWOfficer | Sell | 17.3k | $31.67 | $548k | Mar 5, 2026 |
| SAVAGE BRIANOfficer | Sell | 1.1k | $31.67 | $36k | Mar 5, 2026 |
| FRANCIS RICHARD DChief Executive Officer | Sell | 20.0k | $31.67 | $634k | Mar 5, 2026 |
| FRANCIS RICHARD DChief Executive Officer | Other | 42.5k | — | — | Mar 5, 2026 |
| SABAG MARKOfficer | Other | 15.7k | — | — | Mar 5, 2026 |
| KALIF ELIYAHU SHARONChief Financial Officer | Other | 19.9k | — | — | Mar 5, 2026 |
| HUGHES ERIC AOfficer | Other | 19.7k | — | — | Mar 5, 2026 |
| FOX CHRISTINEOfficer | Other | 17.8k | — | — | Mar 5, 2026 |
| SHIELDS MATTHEWOfficer | Other | 17.3k | — | — | Mar 5, 2026 |
No analyst notes on TEVA yet.
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 7 | 1 | 0 | 0 | Buy1.75 |
| 1 mo ago | 4 | 7 | 1 | 0 | 0 | Buy1.75 |
| 2 mo ago | 5 | 7 | 0 | 0 | 0 | Buy1.58 |
| 3 mo ago | 5 | 7 | 0 | 0 | 0 | Buy1.58 |